Konica Minolta Medical Imaging announced that the AeroDR wireless flat panel detector is now compliant with the Federal Information Processing Standard (FIPS) Publication 140-2 required by the Department of Defense and Veterans Affairs healthcare facilities. The FIPS 140-2 standard is an information technology security accreditation program for wireless hardware and software solutions used in U.S. government departments and industries —  such as the VA hospitals — that collect, store, transfer and disseminate sensitive but unclassified information. The compliance covers the family of AeroDR flat panel detectors and the CS-7 control station.

Boston Scientific Fully Resorbable Scaffold

Accuray Inc. announced that studies on the clinical use of the CyberKnife System continue to demonstrate the benefits of its precise, innovative treatment delivery techniques for stereotactic body radiation therapy (SBRT). More than 30 studies were presented during poster and oral sessions at the 57th Annual Meeting of the American Association of Physicists in Medicine (AAPM) held in Anaheim, California, July 12 – July 16, 2015.

Logicalis Healthcare Solutions, the healthcare-focused arm of Logicalis US, announced formation of a strategic partnership with Ascendian Healthcare Consulting, specializing in medical imaging. Together, the two companies will combine their talents and resources to help healthcare information technology (IT) professionals tackle medical imaging obstacles.

Molecular breast imaging (MBI/BSGI) has been proven to be a highly sensitive imaging technique for the diagnosis of invasive lobular carcinoma (ILC), a position supported by a recent publication in the Journal of the American Medical Association Surgery. Physicians at the Legacy Cancer Institute in Portland, Oregon, reported a sensitivity of 88.9 percent for MBI/BSGI in diagnosing ILC, a difficult-to-diagnose breast cancer.

low-risk prostate cancer, increased radiation, survival benefit, Perelman

Increased radiation dose is associated with higher survival rates in men with medium- and high-risk prostate cancer, but not those at low risk, according to a new study from Penn Medicine Already-high survival rates for men with low-risk prostate cancer were unaffected by higher radiation dosages compared to lower radiation dosages, according to the study published in JAMA Oncology.

BioMimics 3D femoropopliteal stent

Protégé GPS self-expanding peripheral stent system

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now